Rosas Samuel, Sabeh Karim, Kurowicki Jennifer, Buller Leonard, Law Tsun Yee, Roche Martin, Conway Sheila, Hernandez Victor H
Department of Orthopedic Surgery, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Department of Orthopedic Surgery, Holy Cross Hospital, Fort Lauderdale, FL, USA.
Ann Transl Med. 2017 Dec;5(Suppl 3):S34. doi: 10.21037/atm.2017.11.18.
Total hip arthroplasty (THA) is a common and growing procedure in the United States. Concomitantly, there has been a rise in patients diagnosed with certain types of malignancies including solid organ ones. Unfortunately there is limited data available in the literature that describes the use of THA in patients who concomitantly have one of these forms of cancer. Because of the limited data available in the literature regarding this topic, the purpose of this study was to analyze the trends in use of THA among patients with the five most common malignancies in the United States, which include breast, lung, prostate, colon and bladder cancer according to the National Cancer Institute (NCI).
We conducted a retrospective review of the entire Medicare patient population to analyze the use of THA in patients with a diagnosis of solid organ malignancy including breast, lung, prostate, colon and bladder cancer.
Our analysis of over 14 million patients, demonstrate that THA is not as commonly performed procedure in patients with such diagnoses with a 0.26% prevalence. The mean incidence of THA was 0.29%, 0.17%, 0.31%, 0.33% and 0.36% for patients with breast, lung, prostate, colon and bladder cancer respectively.
THA in cancer patients are not frequently performed but the use of this technique has increased significantly in patients with lung, prostate and bladder cancer.
全髋关节置换术（THA）在美国是一种常见且应用日益广泛的手术。与此同时，被诊断患有某些类型恶性肿瘤（包括实体器官恶性肿瘤）的患者数量有所增加。遗憾的是，文献中关于在患有这些癌症类型之一的患者中使用THA的可用数据有限。由于文献中关于该主题的可用数据有限，本研究的目的是分析美国五种最常见恶性肿瘤患者（根据美国国立癌症研究所（NCI）的数据，包括乳腺癌、肺癌、前列腺癌、结肠癌和膀胱癌）中THA的使用趋势。
我们对整个医疗保险患者群体进行了回顾性分析，以分析在诊断为实体器官恶性肿瘤（包括乳腺癌、肺癌、前列腺癌、结肠癌和膀胱癌）的患者中THA的使用情况。
我们对超过1400万患者的分析表明，在患有此类诊断的患者中，THA并非常见手术，患病率为0.26%。乳腺癌、肺癌、前列腺癌、结肠癌和膀胱癌患者的THA平均发病率分别为0.29%、0.17%、0.31%、0.33%和0.36%。
癌症患者中THA的实施并不频繁，但在肺癌、前列腺癌和膀胱癌患者中，该技术的使用显著增加。
